Not possible to specify

441 trials 102 recruiting

Filter these 441 trials by phase, country and sponsor.

Open in Search →

A Clinical Trial to Assess a New Anti-Cancer Treatment (called DSB2455) Given On Its Own in Patients with Advanced Malignancies Recruiting

2023-508805-26-00 patients with active brain metastases, where the primar 1 2024-10-23
A Phase 3 Study With Randomized Withdrawal/Dose Up Investigating the Efficacy, Safety, and Tolerability of Ritlecitinib in Participants With… Recruiting

2023-505804-42-00 NON SEGMENTAL VITILIGO 5 2024-07-10
Incidence of postoperative residual neuromuscular blockade following the administration of rocuronium in thoracic surgical patients: a rando… Recruiting

2023-504745-31-00 Anesthesia and Analgesia, patient safety 6 2024-06-18
Single-Dose Study in Healthy Participants to Compare the Bioavailability of One Film-Coated Mini-Tablet of Indapamide SR 1.5 mg versus One F… Recruiting

2026-526040-13-00 No medical condition. 2 2026-05-25
A Phase 3 study of Hetrombopag in patients with low blood platelet count (thrombocytopenia) caused by chemotherapy Recruiting

2025-524209-34-00 Chemotherapy induced thrombocytopenia 5 2026-05-20
Study on the influence of FLUMAzenil regarding the incidence of pediatric emergence delirium (ED) in children undergoing ENT surgery – FLUMA… Recruiting

2025-523543-36-00 pediatric emergence delirium 11 2026-05-18
PHARMACOKINETICS OF PETRELINTIDE FOLLOWING ADMINISTRATION TO PARTICIPANTS WITH IMPAIRED HEPATIC FUNCTION Recruiting

2025-523641-10-00 Healthy / hepatic impaired volunteers only study to ass 3 2026-05-18
Bioequivalence clinical trial of two formulations of canagliflozin Recruiting

2026-525944-14-00 Healthy volunteers 2 2026-05-14
A research study looking into blood levels of the medicine NNC0487 0111 in the body and how well it is tolerated in people with reduced live… Recruiting

2025-521647-20-00 hepatic impairment 3 2026-05-12
A study to test how different doses of BI 3814916 are tolerated by healthy people Recruiting

2025-523262-25-00 healthy volunteer trial 1 2026-05-11
Pilot, randomized, crossover, comparative bioavailability study of two tadalafil formulations (oral suspension and film-coated tablets) afte… Recruiting

2026-525930-47-00 Healthy volunteers 3 2026-05-07
A PHASE 1, OPEN-LABEL, SINGLE-DOSE MASS BALANCE AND METABOLITE PROFILING STUDY OF 14C-LABELED IZICOPAN (INF904) IN HEALTHY MALE PARTICIPANTS Recruiting

2026-525517-31-00 Not applicable, healthy volunteers 3 2026-05-04
Evaluation of postoperative recovery when combining intravenous lidocaine with ropivacaine infiltration in laparoscopic colorectal oncologic… Recruiting

2025-523207-29-00 colorectal cancer laparoscopic surgery 6 2026-04-24
Phase 1, Randomized, Open-label, Single center study to evaluate Pharmacokinetic and Bioequivalence of Levonorgestrel Vaginal Delivery Syste… Recruiting

2025-524330-25-00 No medical condition 3 2026-04-21
A study in healthy people to test how vicadrostat affects the heart Recruiting

2025-524106-14-00 Healthy volunteer trial 3 2026-04-20
A study in healthy men to test how well different doses of BI 3821001 are tolerated Recruiting

2025-523899-23-00 Healthy volunteer trial 1 2026-04-15
Immunosuppression regimen reduction in kidney transplantation recipients admitted to the intensive care unit in the setting of septic shock … Recruiting

2024-518493-14-00 kidney transplant 10 2026-04-10
A research study looking at how NNC0487-0111 affects food intake, appetite and metabolism after meals in people with obesity Recruiting

2025-521393-34-00 Participants with obesity, but otherwise healthy 3 2026-03-19
A Phase I, open-label, non-randomized study to assess the absorption, distribution, metabolism and excretion (ADME) and pharmacokinetics of … Recruiting

2025-524172-29-00 Healthy volunteers 3 2026-03-18
ADCX-020 for the treatment of patients with locally advanced or metastatic cancers Recruiting

2025-523959-65-00 Locally Advanced or Metastatic Solid Tumors 1 2026-03-17
A trial to learn how well AZD4144 works, how safe it is, and how it moves throughout the body over time in adults with acute kidney injury c… Recruiting

2025-522232-13-00 Sepsis-associated acute kidney injury (AKI) 4 2026-03-06
The POWER trial: A randomised, two-armed open label phase 3 clinical trial on personalised dose optimisation with adjuvant tamoxifen therapy… Recruiting

2025-522240-40-00 Breast Cancer 5 2026-03-05
The PEARL trial: Prevention of hepatic Encephalopathy by administration of Rifaximin and Lactulose in patients with liver cirrhosis undergoi… Recruiting

2024-512040-28-01 Confirmed diagnosis of Alcoholic liver cirrhosis 6 2026-03-01
Study of exposure to substances prohibited by the World Anti-Doping Agency in healthy volunteers (ESPAMA_4). Proof of concept Recruiting

2025-521814-25-01 Healthy volunteers 3 2026-02-11